Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma

MLA

Yupeng Jiang, et al. “Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma.” Frontiers in Cell and Developmental Biology, vol. 9, Jan. 2022. EBSCOhost, https://doi.org/10.3389/fcell.2021.817085.

APA

Yupeng Jiang, Wenhao Ouyang, Chenzi Zhang, Yunfang Yu, & Herui Yao. (2022). Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.817085

Chicago

Yupeng Jiang, Wenhao Ouyang, Chenzi Zhang, Yunfang Yu, and Herui Yao. 2022. “Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma.” Frontiers in Cell and Developmental Biology 9 (January). doi:10.3389/fcell.2021.817085.